Skip to content

ATARA BIOTHERAPEUTICS, INC.: filings

Every ATARA BIOTHERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 48 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 2026441250001193125-26-346885
10-Q2026-05-12fiscal Q1 202643890001193125-26-219482
10-K2026-03-16fiscal FY 2025521050001193125-26-108361
10-Q2025-11-12fiscal Q3 2025491400001193125-25-276219
10-Q2025-08-11fiscal Q2 2025491360000950170-25-106550
10-Q2025-05-15fiscal Q1 2025491010000950170-25-072040
10-K2025-03-07fiscal FY 2024511030000950170-25-035507
10-Q2024-11-12fiscal Q3 2024461320000950170-24-125389
10-Q2024-08-12fiscal Q2 2024461280000950170-24-095533
10-Q2024-05-09fiscal Q1 202446960000950170-24-056959
10-K2024-03-28fiscal FY 2023511020000950170-24-037644
10-Q2023-11-01fiscal Q3 2023461320000950170-23-057147
10-Q2023-08-08fiscal Q2 2023471320000950170-23-039820
10-Q2023-05-08fiscal Q1 202347980000950170-23-018820
10-K2023-02-08fiscal FY 2022491280000950170-23-002185
10-Q2022-11-08fiscal Q3 2022451270000950170-22-023248
10-Q2022-08-08fiscal Q2 2022451230000950170-22-015536
10-Q2022-05-05fiscal Q1 202239820001564590-22-018253
10-K2022-02-28fiscal FY 2021441130001564590-22-007633
10-Q2021-11-04fiscal Q3 2021401090001564590-21-054261
10-Q2021-08-09fiscal Q2 2021401050001564590-21-042636
10-Q2021-05-04fiscal Q1 202138800001564590-21-023337
10-K2021-03-01fiscal FY 2020441140001564590-21-009854
10-Q2020-11-09fiscal Q3 2020371040001564590-20-052503
10-Q2020-08-05fiscal Q2 2020371000001564590-20-036808
10-Q2020-05-06fiscal Q1 202035740001564590-20-021960
10-K2020-02-27fiscal FY 2019421060001564590-20-007027
10-Q2019-11-07fiscal Q3 2019381040001564590-19-041368
10-Q2019-08-08fiscal Q2 2019381000001564590-19-030426
10-Q2019-05-09fiscal Q1 201934690001564590-19-017599
10-K2019-02-26fiscal FY 201837980001564590-19-004275
10-Q2018-11-06fiscal Q3 201833860001564590-18-027095
10-Q2018-08-01fiscal Q2 201833860001564590-18-018263
10-Q2018-05-08fiscal Q1 201829600001564590-18-011469
10-K2018-02-27fiscal FY 201729750001564590-18-003390
10-Q2017-11-09fiscal Q3 201729790001564590-17-023005
10-Q2017-08-07fiscal Q2 201729790001564590-17-016028
10-Q2017-05-04fiscal Q1 201728590001564590-17-008828
10-K2017-03-09fiscal FY 201630790001564590-17-003792
10-Q2016-11-04fiscal Q3 201627750001564590-16-027509
10-Q2016-08-08fiscal Q2 201627720001564590-16-023141
10-Q2016-05-06fiscal Q1 201627560001564590-16-018294
10-K2016-03-04fiscal FY 201529740001564590-16-014061
10-Q2015-11-06fiscal Q3 201526660001564590-15-009779
10-Q2015-08-07fiscal Q2 201526650001564590-15-006518
10-Q2015-05-11fiscal Q1 201524490001564590-15-003950
10-K2015-02-26fiscal FY 201425600001564590-15-001038
10-Q2014-11-12fiscal Q3 201425620001564590-14-005463

Inspect the source

Entity
ATARA BIOTHERAPEUTICS, INC. / CIK 0001604464
Captured
2026-09-20T09:25:50.712Z
SEC response SHA-256
5caf8d991bdbf108bf374c4a99fb3db43ca433548e7f8802076ae8c061ebee0b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001604464.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))